AlzeCure Pharma AB (publ)
SSE:ALZCUR.ST
2.49 (SEK) • At close February 20, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | AlzeCure Pharma AB (publ) |
Symbool | ALZCUR.ST |
Munteenheid | SEK |
Prijs | 2.49 |
Beurswaarde | 154,596,630 |
Dividendpercentage | 0% |
52-weken bereik | 2.03 - 6.54 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Martin Jönsson |
Website | https://www.alzecurepharma.se |
An error occurred while fetching data.
Over AlzeCure Pharma AB (publ)
AlzeCure Pharma AB (publ), a pharmaceutical company, develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system. The company is developing drug candidates based on the NeuroRestore, Alzstatin, and Painless research platforms. Its pipeline drug candidates include ACD856, which is in phase I
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (SEK)
Cijfers zijn in miljoenen (SEK)